Skip to search formSkip to main contentSkip to account menu

CALGB 9251 Regimen

A regimen comprised of a prephase (or cytoreductive phase), followed by two different chemotherapy regimens, given on an alternating schedule and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE CALGB 49907 showed the superiority of standard therapy, which included either cyclophosphamide/doxorubicin (AC) or… 
2015
2015
Taxane-based regimens are among the preferred first-line chemotherapy options for metastatic breast cancer, with weekly… 
2011
2011
1018 Background: Dose-dense chemotherapy has become one of the possible standards in breast cancer patients (pts). Both, CALGB… 
2009
2009
11009 Background: Effective treatment of breast cancer through the targeting of the HER2 protein in human breast cancer… 
2009
2009
CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts Abstract #703 Background: The I-SPY trial is a multi… 
Review
2006
Review
2006
The Cancer and Leukemia Group B is dedicated to developing and implementing training programs that will enhance the skills and… 
Highly Cited
2004
Highly Cited
2004
3500 Background: Irinotecan prolongs survival in second line 5FU-refractory metastatic colorectal cancer (MCRC). First line… 
Highly Cited
2004
Highly Cited
2004
3500 Background: Irinotecan prolongs survival in second line 5FU-refractory metastatic colorectal cancer (MCRC). First line…